To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Amanda Zapp currently serves as the Vice President of Marketing and Communications at Proactive Capital Group. Amanda comes with vast experience in the marketing and communications field specializing in the financial services, non-profit, and consumer products industries. Most recently, Amanda served as a Senior Marketing Associate at Cantor Fitzgerald where she managed social media and digital marketing and also created investor presentations for executive management. She also managed the annual 9/11 charity event which received numerous awards from PR Daily and the Financial Communications Society. In addition, she served as Publicist to the Cantor Fitzgerald Relief Fund's President and Co-Founder. Previously, Amanda
was a marketing consultant for Evian where she created presentations for the U.S. sales team. Amanda began her career are a graduate and research assistant at Iona College.
Amanda graduated summa cum laude with a B.A. in Mass Communications and received an MBA in marketing with honors from Iona College.
Commodities, Stocks - long, Stocks - short, Tech stocks
Proactive Capital Group
ProActive Capital Resources, through its Digital Media and Investor Relations divisions, is a leader in utilizing emerging technologies to democratize the corporate messaging process. ProActiveNewsRoom is an integrated digital media portal that serves as both a destination and a distribution point - providing
forward-thinking companies with a platform for raised visibility and providing investors with a much-needed transparent view into these companies. Our goal is to maximize the opportunities afforded by cutting-edge web technologies so that deserving, innovative but underserved companies can share their message with an educated and engaged investor audience. These digital media platforms along with our vast and unparalled human network, allow for ProActive to provide the first truly-integrated strategic messaging and investor relations service to the best emerging companies.
Currently, there are no blog details for Amanzda87.
Currently, there are no book details for Amanzda87.
Completion of Patient Enrollment for Phase I Clinical Trial for Liver #Cancer by @CellBioMedGroup $CBMG #Biotech
Aug 22, 2013
Xignite quote data
© 2015 Seeking Alpha